Subject(s)

Betacoronavirus , Coronavirus Infections/blood , Pandemics , Pneumonia, Viral/blood , Pregnancy Complications, Hematologic/etiology , Pregnancy Complications, Infectious/blood , Thromboembolism/prevention & control , Thrombophilia/etiology , Anticoagulants/therapeutic use , Autoantibodies/blood , Betacoronavirus/isolation & purification , Betacoronavirus/physiology , Blood Proteins/analysis , COVID-19 , Cerebrovascular Disorders/etiology , Cerebrovascular Disorders/prevention & control , Contraindications, Drug , Coronavirus Infections/complications , Cytokine Release Syndrome/blood , Cytokine Release Syndrome/etiology , Disseminated Intravascular Coagulation/drug therapy , Disseminated Intravascular Coagulation/etiology , Endothelial Cells/virology , Female , Heparin, Low-Molecular-Weight/administration & dosage , Heparin, Low-Molecular-Weight/therapeutic use , Humans , Partial Thromboplastin Time , Plasma , Pneumonia, Viral/complications , Postpartum Hemorrhage/drug therapy , Postpartum Hemorrhage/therapy , Pregnancy , Pregnancy Complications, Hematologic/drug therapy , Puerperal Disorders/blood , Puerperal Disorders/drug therapy , Puerperal Disorders/etiology , SARS-CoV-2 , Thromboembolism/etiology , Thrombophilia/drug therapy , Tranexamic Acid/adverse effects , Tranexamic Acid/therapeutic use